Free Trial

Rigel Pharmaceuticals (RIGL) SEC Filings & 10K Form

Rigel Pharmaceuticals logo
$18.72 -0.84 (-4.29%)
Closing price 04:00 PM Eastern
Extended Trading
$18.65 -0.07 (-0.37%)
As of 04:42 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Rigel Pharmaceuticals SEC Filings

DateFilerForm TypeView
04/17/2025
8:35 AM
BlackRock, Inc. (Filed by)
Rigel Pharmaceuticals (Subject)
Form SCHEDULE 13G/A
04/10/2025
3:06 PM
Rigel Pharmaceuticals (Filer)
Form DEF 14A
04/10/2025
3:07 PM
Rigel Pharmaceuticals (Filer)
Form DEFA14A
04/10/2025
3:10 PM
Rigel Pharmaceuticals (Filer)
Form ARS
03/27/2025
8:16 AM
Rigel Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/19/2025
7:55 PM
Furey Raymond J. (Reporting)
Rigel Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2025
7:56 PM
Rigel Pharmaceuticals (Issuer)
RODRIGUEZ RAUL R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2025
7:56 PM
Rigel Pharmaceuticals (Issuer)
Rojkjaer Lisa (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2025
7:56 PM
Rigel Pharmaceuticals (Issuer)
Santos David A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2025
7:56 PM
Rigel Pharmaceuticals (Issuer)
Schorno Dean L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/10/2025
4:41 PM
Frohlich Mark W (Reporting)
Rigel Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
03/10/2025
4:42 PM
Frohlich Mark W (Reporting)
Rigel Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/10/2025
4:22 PM
Rigel Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2025
4:18 PM
ARMISTICE CAPITAL, LLC (Filed by)
Rigel Pharmaceuticals (Subject)
Form SCHEDULE 13G/A
02/07/2025
12:42 PM
Invesco Ltd. (Filed by)
Rigel Pharmaceuticals (Subject)
Form SCHEDULE 13G/A
02/06/2025
7:26 PM
Furey Raymond J. (Reporting)
Rigel Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/06/2025
7:27 PM
Rigel Pharmaceuticals (Issuer)
RODRIGUEZ RAUL R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/06/2025
7:27 PM
Rigel Pharmaceuticals (Issuer)
Santos David A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/06/2025
7:27 PM
Rigel Pharmaceuticals (Issuer)
Schorno Dean L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2025
2:40 PM
Rigel Pharmaceuticals (Subject)
RODRIGUEZ RAUL R (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/05/2025
2:41 PM
Furey Raymond J. (Reporting)
Rigel Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/05/2025
2:43 PM
Rigel Pharmaceuticals (Subject)
Schorno Dean L (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/05/2025
2:58 PM
Rigel Pharmaceuticals (Subject)
Santos David A (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/05/2025
12:23 PM
BlackRock, Inc. (Filed by)
Rigel Pharmaceuticals (Subject)
Form SCHEDULE 13G
02/04/2025
3:39 PM
Rigel Pharmaceuticals (Subject)
Schorno Dean L (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/04/2025
3:30 PM
Rigel Pharmaceuticals (Subject)
RODRIGUEZ RAUL R (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/04/2025
3:20 PM
Rigel Pharmaceuticals (Subject)
Santos David A (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/04/2025
3:21 PM
Furey Raymond J. (Reporting)
Rigel Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/31/2025
5:47 PM
Rigel Pharmaceuticals (Issuer)
Rojkjaer Lisa (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2025
5:45 PM
Furey Raymond J. (Reporting)
Rigel Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2025
5:47 PM
Rigel Pharmaceuticals (Issuer)
Santos David A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2025
5:47 PM
Rigel Pharmaceuticals (Issuer)
Schorno Dean L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2025
5:47 PM
Rigel Pharmaceuticals (Issuer)
RODRIGUEZ RAUL R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/28/2025
7:49 PM
Rigel Pharmaceuticals (Issuer)
RODRIGUEZ RAUL R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/24/2025
3:38 PM
Masuda Esteban (Reporting)
Rigel Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/13/2025
7:15 AM
Rigel Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/26/2024
7:01 PM
Rigel Pharmaceuticals (Issuer)
Schorno Dean L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/26/2024
7:01 PM
Rigel Pharmaceuticals (Issuer)
RODRIGUEZ RAUL R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/26/2024
7:01 PM
Rigel Pharmaceuticals (Issuer)
Santos David A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/08/2024
8:33 AM
Invesco Ltd. (Filed by)
Rigel Pharmaceuticals (Subject)
Form SC 13G
11/07/2024
3:22 PM
Rigel Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
The Man I Turn to In Times Like This (Ad)

A storm is brewing in the markets: new tariffs, recession warnings, and panic in the headlines. That’s when publisher Brett Aitken turns to Whitney Tilson—a man CNBC once dubbed “The Prophet.” Tilson just released a new prediction that runs counter to what mainstream finance is telling you.

Market chaos? Hear Tilson’s take now
09/19/2024
3:01 PM
Rigel Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/04/2024
7:36 PM
Rigel Pharmaceuticals (Issuer)
RODRIGUEZ RAUL R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/04/2024
7:33 PM
Rigel Pharmaceuticals (Issuer)
Schorno Dean L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/03/2024
7:30 AM
Rigel Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/11/2024
11:15 PM
Rigel Pharmaceuticals (Filer)
Form EFFECT
06/27/2024
3:31 PM
Rigel Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/25/2024
7:45 AM
Rigel Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/29/2024
6:19 PM
Ali-Jackson Kamil (Reporting)
Rigel Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/29/2024
6:20 PM
HANNAH ALISON L. (Reporting)
Rigel Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/29/2024
6:20 PM
Kotzin Brian L. (Reporting)
Rigel Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/29/2024
6:20 PM
LAPOINTE ANTHONY GREGG (Reporting)
Rigel Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/29/2024
6:21 PM
MOOS WALTER H (Reporting)
Rigel Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/29/2024
6:21 PM
Rigel Pharmaceuticals (Issuer)
Wasman Jane (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/29/2024
3:06 PM
Rigel Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/07/2024
3:05 PM
Rigel Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:RIGL) was last updated on 5/1/2025 by MarketBeat.com Staff
From Our Partners